{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:13:44Z","timestamp":1791515624290,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejmech.2023.115564","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T02:09:23Z","timestamp":1686535763000},"page":"115564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Development of diphenylmethylpiperazine hybrids of chloroquinoline and triazolopyrimidine using Petasis reaction as new cysteine proteases inhibitors for malaria therapeutics"],"prefix":"10.1016","volume":"258","author":[{"given":"Hari","family":"Madhav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarosh S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeba","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Srinivas","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Ataur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiema","family":"Ahmedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhat","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souvik","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat C.","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puran Singh","family":"Sijwali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-2056","authenticated-orcid":false,"given":"Nasimul","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115564_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113981","article-title":"Design, synthesis, and characterization of novel aminoalcohol quinolines with strong in vitro antimalarial activity","volume":"228","author":"Dassonville-Klimpt","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib2","series-title":"World Malaria Report 2022","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115564_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112955","article-title":"An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins","volume":"210","author":"Madhav","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114408","article-title":"Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents","volume":"238","author":"Poje","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105671","article-title":"Synthesis, biological evaluation, Structure \u2212 Activity relationship studies of quinoline-imidazole derivatives as potent antimalarial agents","volume":"121","author":"Roy","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib6","doi-asserted-by":"crossref","first-page":"39410","DOI":"10.1039\/C9RA06571G","article-title":"Quinoline-triazole hybrids inhibit falcipain-2 and arrest the development of Plasmodium falciparum at the trophozoite stage","volume":"9","author":"Singh","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115564_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejmech.2017.12.051","article-title":"Antimalarial naphthoquinones. Synthesis via click chemistry, in vitro activity , docking to Pf DHODH and SAR of lapachol-based compounds","volume":"145","author":"Brand\u00e3o","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/42.3.333","article-title":"In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents","volume":"42","author":"Pradines","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2023.115564_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijpddr.2018.10.002","article-title":"Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity","volume":"8","author":"Aguiar","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2023.115564_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02347-17","article-title":"Synthesis, biological evaluation, and molecular modeling studies of chiral chloroquine analogues as antimalarial agents","volume":"62","author":"Kondaparla","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115564_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acsmedchemlett.9b00669","article-title":"Synthesis of novel G factor or chloroquine-artemisinin hybrids and conjugates with potent antiplasmodial activity","volume":"11","author":"Pepe","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115564_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115832","article-title":"Antimalarial and anti-inflammatory activities of new chloroquine and primaquine hybrids: targeting the blockade of malaria parasite transmission","volume":"28","author":"Boechat","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib13","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/ph14111174","article-title":"Synthesis, molecular docking, and antimalarial activity of hybrid 4-Aminoquinoline-pyrano[2,3-c]pyrazole derivatives","volume":"14","author":"Shamsuddin","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115564_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/415673a","article-title":"The pathogenic basis of malaria","volume":"415","author":"Miller","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115564_bib15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.ijpara.2004.10.003","article-title":"Cysteine proteases of malaria parasites","volume":"34","author":"Rosenthal","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115564_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00394","article-title":"Structural insights into key Plasmodium proteases as therapeutic drug targets","volume":"10","author":"Mishra","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2023.115564_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115155","article-title":"Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity","volume":"28","author":"Rana","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib18","article-title":"Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: design, synthesis and antimalarial efficacy studies","author":"Singh","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114303","article-title":"Tandem construction of biological relevant aliphatic 5-membered N-heterocycles","volume":"235","author":"\u0141owicki","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114438","article-title":"Cascade synthetic strategies opening access to medicinal-relevant aliphatic 3- and 4-membered N-heterocyclic scaffolds","volume":"238","author":"\u0141owicki","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib21","doi-asserted-by":"crossref","first-page":"11245","DOI":"10.1021\/acs.chemrev.9b00214","article-title":"Reactivity and synthetic applications of multicomponent Petasis reactions","volume":"119","author":"Wu","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2023.115564_bib22","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1039\/D1MD00038A","article-title":"Design, synthesis, crystal structure and anti-plasmodial evaluation of tetrahydrobenzo[4,5]thieno[2,3- d ]pyrimidine derivatives","volume":"12","author":"Pal","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib23","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1021\/jm300286a","article-title":"Lead optimization of antimalarial propafenone analogues","volume":"55","author":"Lowes","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib24","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/jm00035a017","article-title":"The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine","volume":"37","author":"O'Neill","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib25","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/jm030796n","article-title":"Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials","volume":"46","author":"O'Neill","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02781-21","article-title":"Bazedoxifene, a postmenopausal drug, acts as an antimalarial and inhibits hemozoin formation","volume":"10","author":"Sudhakar","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2023.115564_bib27","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/iai.63.6.2120-2125.1995","article-title":"Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase","volume":"63","author":"Salas","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2023.115564_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/expr.1995.1033","article-title":"Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites","volume":"80","author":"Rosenthal","year":"1995","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115564_bib29","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1128\/AAC.40.7.1600","article-title":"Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors","volume":"40","author":"Rosenthal","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115564_bib30","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1016\/j.bmc.2017.10.041","article-title":"Ionic liquid mediated stereoselective synthesis of alanine linked hybrid quinazoline-4(3H)-one derivatives perturbing the malarial reductase activity in folate pathway","volume":"25","author":"Patel","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib31","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/j.bmc.2019.06.038","article-title":"Green synthesis, biological evaluation, molecular docking studies and 3D-QSAR analysis of novel phenylalanine linked quinazoline-4(3H)-one-sulphonamide hybrid entities distorting the malarial reductase activity in folate pathway","volume":"27","author":"Patel","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115564_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900099","article-title":"Design and synthesis of leucine\u2010linked quinazoline\u20104(3 H)\u2010one\u2010sulphonamide molecules distorting malarial reductase activity in the folate pathway","volume":"352","author":"Patel","year":"2019","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2023.115564_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115564_bib35","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1073\/pnas.0307720101","article-title":"Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum","volume":"101","author":"Sijwali","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.115564_bib36","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1016\/j.bmc.2017.10.017","article-title":"Discovery of new antimalarial agents: second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely","volume":"25","author":"Chen","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib37","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1021\/jm801622x","article-title":"Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening","volume":"52","author":"Li","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1211\/146080899128734785","article-title":"Aliphatic \u03b1,\u03b3-bis(Amides) of methotrexate. Influence of chain length on in-vitro activity against sensitive and resistant tumour cells","volume":"5","author":"Pignatello","year":"1999","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.ejmech.2023.115564_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700088","article-title":"Diarylpyrazole ligated dihydropyrimidine hybrids as potent non-classical antifolates and their efficacy against Plasmodium falciparum","volume":"350","author":"Bhatt","year":"2017","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2023.115564_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115055","article-title":"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents","volume":"248","author":"Pal","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115564_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115074","article-title":"In silico, in vitro and in vivo evaluation of natural Bignoniaceous naphthoquinones in comparison with atovaquone targeting the selection of potential antimalarial candidates","volume":"401","author":"do Nascimento","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423005305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423005305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:53:55Z","timestamp":1759330435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423005305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":41,"alternative-id":["S0223523423005305"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115564","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of diphenylmethylpiperazine hybrids of chloroquinoline and triazolopyrimidine using Petasis reaction as new cysteine proteases inhibitors for malaria therapeutics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115564"}}